nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP1A2—Pentoxifylline—systemic scleroderma	0.0529	0.32	CbGbCtD
Ropinirole—CYP1A2—Leflunomide—systemic scleroderma	0.0505	0.305	CbGbCtD
Ropinirole—HTR2B—cardial valve—systemic scleroderma	0.0366	0.332	CbGeAlD
Ropinirole—CYP2D6—Captopril—systemic scleroderma	0.0326	0.197	CbGbCtD
Ropinirole—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0163	0.0988	CbGbCtD
Ropinirole—CYP3A4—Prednisone—systemic scleroderma	0.0131	0.079	CbGbCtD
Ropinirole—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0112	0.101	CbGeAlD
Ropinirole—HTR2A—pulmonary artery—systemic scleroderma	0.00792	0.0719	CbGeAlD
Ropinirole—HTR1B—artery—systemic scleroderma	0.00611	0.0554	CbGeAlD
Ropinirole—HTR1D—artery—systemic scleroderma	0.00591	0.0536	CbGeAlD
Ropinirole—HTR1B—blood vessel—systemic scleroderma	0.00476	0.0431	CbGeAlD
Ropinirole—HTR1D—blood vessel—systemic scleroderma	0.0046	0.0418	CbGeAlD
Ropinirole—HTR2A—artery—systemic scleroderma	0.00294	0.0266	CbGeAlD
Ropinirole—HTR2A—endothelium—systemic scleroderma	0.00248	0.0225	CbGeAlD
Ropinirole—HTR1D—connective tissue—systemic scleroderma	0.00236	0.0214	CbGeAlD
Ropinirole—HTR2A—blood vessel—systemic scleroderma	0.00229	0.0207	CbGeAlD
Ropinirole—HTR2B—smooth muscle tissue—systemic scleroderma	0.00201	0.0182	CbGeAlD
Ropinirole—HTR2B—skin of body—systemic scleroderma	0.00198	0.018	CbGeAlD
Ropinirole—HTR2B—digestive system—systemic scleroderma	0.00159	0.0144	CbGeAlD
Ropinirole—HTR2B—tendon—systemic scleroderma	0.00151	0.0137	CbGeAlD
Ropinirole—ADRA2A—connective tissue—systemic scleroderma	0.00138	0.0125	CbGeAlD
Ropinirole—HTR2B—lung—systemic scleroderma	0.00132	0.012	CbGeAlD
Ropinirole—ADRA2C—tendon—systemic scleroderma	0.00119	0.0108	CbGeAlD
Ropinirole—HTR2A—connective tissue—systemic scleroderma	0.00117	0.0106	CbGeAlD
Ropinirole—CYP1A2—digestive system—systemic scleroderma	0.00108	0.00983	CbGeAlD
Ropinirole—HTR2A—smooth muscle tissue—systemic scleroderma	0.00107	0.00973	CbGeAlD
Ropinirole—DRD2—lung—systemic scleroderma	0.00107	0.00973	CbGeAlD
Ropinirole—ADRA2C—lung—systemic scleroderma	0.00104	0.00946	CbGeAlD
Ropinirole—ADRA2A—tendon—systemic scleroderma	0.000948	0.0086	CbGeAlD
Ropinirole—CYP1A2—lung—systemic scleroderma	0.000905	0.00821	CbGeAlD
Ropinirole—HTR2A—digestive system—systemic scleroderma	0.000847	0.00768	CbGeAlD
Ropinirole—ADRA2A—lung—systemic scleroderma	0.000832	0.00755	CbGeAlD
Ropinirole—HTR2A—tendon—systemic scleroderma	0.000806	0.00731	CbGeAlD
Ropinirole—CYP3A4—digestive system—systemic scleroderma	0.000784	0.00711	CbGeAlD
Ropinirole—CYP2D6—digestive system—systemic scleroderma	0.000772	0.007	CbGeAlD
Ropinirole—HTR2A—lung—systemic scleroderma	0.000707	0.00642	CbGeAlD
Ropinirole—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000175	0.000241	CcSEcCtD
Ropinirole—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000174	0.00024	CcSEcCtD
Ropinirole—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000174	0.00024	CcSEcCtD
Ropinirole—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000174	0.00024	CcSEcCtD
Ropinirole—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000174	0.00024	CcSEcCtD
Ropinirole—Myocardial infarction—Prednisone—systemic scleroderma	0.000174	0.00024	CcSEcCtD
Ropinirole—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000174	0.00024	CcSEcCtD
Ropinirole—Breast disorder—Methotrexate—systemic scleroderma	0.000174	0.00024	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000173	0.000239	CcSEcCtD
Ropinirole—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000239	CcSEcCtD
Ropinirole—Hypersensitivity—Azathioprine—systemic scleroderma	0.000173	0.000238	CcSEcCtD
Ropinirole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000173	0.000238	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000238	CcSEcCtD
Ropinirole—Insomnia—Lisinopril—systemic scleroderma	0.000172	0.000237	CcSEcCtD
Ropinirole—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000237	CcSEcCtD
Ropinirole—Paraesthesia—Lisinopril—systemic scleroderma	0.000171	0.000236	CcSEcCtD
Ropinirole—Vomiting—Captopril—systemic scleroderma	0.000171	0.000236	CcSEcCtD
Ropinirole—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000235	CcSEcCtD
Ropinirole—Dyspnoea—Lisinopril—systemic scleroderma	0.00017	0.000234	CcSEcCtD
Ropinirole—Rash—Captopril—systemic scleroderma	0.000169	0.000234	CcSEcCtD
Ropinirole—Dermatitis—Captopril—systemic scleroderma	0.000169	0.000234	CcSEcCtD
Ropinirole—Somnolence—Lisinopril—systemic scleroderma	0.000169	0.000233	CcSEcCtD
Ropinirole—Headache—Captopril—systemic scleroderma	0.000168	0.000232	CcSEcCtD
Ropinirole—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000232	CcSEcCtD
Ropinirole—Dyspepsia—Lisinopril—systemic scleroderma	0.000167	0.000231	CcSEcCtD
Ropinirole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000167	0.00023	CcSEcCtD
Ropinirole—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000167	0.00023	CcSEcCtD
Ropinirole—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000167	0.00023	CcSEcCtD
Ropinirole—Asthma—Methotrexate—systemic scleroderma	0.000166	0.000229	CcSEcCtD
Ropinirole—Infection—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000229	CcSEcCtD
Ropinirole—Decreased appetite—Lisinopril—systemic scleroderma	0.000165	0.000228	CcSEcCtD
Ropinirole—Eosinophilia—Methotrexate—systemic scleroderma	0.000164	0.000227	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000164	0.000227	CcSEcCtD
Ropinirole—Fatigue—Lisinopril—systemic scleroderma	0.000164	0.000226	CcSEcCtD
Ropinirole—Shock—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000226	CcSEcCtD
Ropinirole—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000226	CcSEcCtD
Ropinirole—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000225	CcSEcCtD
Ropinirole—Hypersensitivity—Leflunomide—systemic scleroderma	0.000163	0.000225	CcSEcCtD
Ropinirole—Pancreatitis—Methotrexate—systemic scleroderma	0.000163	0.000225	CcSEcCtD
Ropinirole—Pain—Lisinopril—systemic scleroderma	0.000163	0.000225	CcSEcCtD
Ropinirole—Constipation—Lisinopril—systemic scleroderma	0.000163	0.000225	CcSEcCtD
Ropinirole—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000225	CcSEcCtD
Ropinirole—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000223	CcSEcCtD
Ropinirole—Bradycardia—Prednisone—systemic scleroderma	0.000162	0.000223	CcSEcCtD
Ropinirole—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000222	CcSEcCtD
Ropinirole—Diarrhoea—Azathioprine—systemic scleroderma	0.00016	0.000221	CcSEcCtD
Ropinirole—Haemoglobin—Prednisone—systemic scleroderma	0.00016	0.000221	CcSEcCtD
Ropinirole—Nausea—Captopril—systemic scleroderma	0.00016	0.00022	CcSEcCtD
Ropinirole—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000159	0.00022	CcSEcCtD
Ropinirole—Haemorrhage—Prednisone—systemic scleroderma	0.000159	0.000219	CcSEcCtD
Ropinirole—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000219	CcSEcCtD
Ropinirole—Asthenia—Leflunomide—systemic scleroderma	0.000159	0.000219	CcSEcCtD
Ropinirole—Hallucination—Prednisone—systemic scleroderma	0.000158	0.000218	CcSEcCtD
Ropinirole—Feeling abnormal—Lisinopril—systemic scleroderma	0.000157	0.000216	CcSEcCtD
Ropinirole—Pruritus—Leflunomide—systemic scleroderma	0.000157	0.000216	CcSEcCtD
Ropinirole—Connective tissue disorder—Prednisone—systemic scleroderma	0.000156	0.000216	CcSEcCtD
Ropinirole—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000215	CcSEcCtD
Ropinirole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000156	0.000215	CcSEcCtD
Ropinirole—Dysuria—Methotrexate—systemic scleroderma	0.000155	0.000214	CcSEcCtD
Ropinirole—Dizziness—Azathioprine—systemic scleroderma	0.000155	0.000214	CcSEcCtD
Ropinirole—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000154	0.000213	CcSEcCtD
Ropinirole—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000153	0.000211	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000152	0.00021	CcSEcCtD
Ropinirole—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000152	0.000209	CcSEcCtD
Ropinirole—Asthenia—Mycophenolic acid—systemic scleroderma	0.000152	0.000209	CcSEcCtD
Ropinirole—Diarrhoea—Leflunomide—systemic scleroderma	0.000151	0.000209	CcSEcCtD
Ropinirole—Urticaria—Lisinopril—systemic scleroderma	0.000151	0.000209	CcSEcCtD
Ropinirole—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000208	CcSEcCtD
Ropinirole—Abdominal pain—Lisinopril—systemic scleroderma	0.00015	0.000208	CcSEcCtD
Ropinirole—Body temperature increased—Lisinopril—systemic scleroderma	0.00015	0.000208	CcSEcCtD
Ropinirole—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000207	CcSEcCtD
Ropinirole—Pruritus—Mycophenolic acid—systemic scleroderma	0.000149	0.000206	CcSEcCtD
Ropinirole—Vomiting—Azathioprine—systemic scleroderma	0.000149	0.000206	CcSEcCtD
Ropinirole—Pneumonia—Methotrexate—systemic scleroderma	0.000149	0.000206	CcSEcCtD
Ropinirole—Eye disorder—Prednisone—systemic scleroderma	0.000149	0.000205	CcSEcCtD
Ropinirole—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000205	CcSEcCtD
Ropinirole—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000205	CcSEcCtD
Ropinirole—Infestation NOS—Methotrexate—systemic scleroderma	0.000148	0.000204	CcSEcCtD
Ropinirole—Infestation—Methotrexate—systemic scleroderma	0.000148	0.000204	CcSEcCtD
Ropinirole—Rash—Azathioprine—systemic scleroderma	0.000148	0.000204	CcSEcCtD
Ropinirole—Dermatitis—Azathioprine—systemic scleroderma	0.000148	0.000204	CcSEcCtD
Ropinirole—Depression—Methotrexate—systemic scleroderma	0.000148	0.000204	CcSEcCtD
Ropinirole—Flushing—Prednisone—systemic scleroderma	0.000148	0.000204	CcSEcCtD
Ropinirole—Headache—Azathioprine—systemic scleroderma	0.000147	0.000203	CcSEcCtD
Ropinirole—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000203	CcSEcCtD
Ropinirole—Dizziness—Leflunomide—systemic scleroderma	0.000146	0.000202	CcSEcCtD
Ropinirole—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000145	0.0002	CcSEcCtD
Ropinirole—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000144	0.000199	CcSEcCtD
Ropinirole—Stomatitis—Methotrexate—systemic scleroderma	0.000144	0.000199	CcSEcCtD
Ropinirole—Angiopathy—Prednisone—systemic scleroderma	0.000144	0.000199	CcSEcCtD
Ropinirole—Conjunctivitis—Methotrexate—systemic scleroderma	0.000144	0.000199	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000199	CcSEcCtD
Ropinirole—Immune system disorder—Prednisone—systemic scleroderma	0.000144	0.000198	CcSEcCtD
Ropinirole—Pain—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000197	CcSEcCtD
Ropinirole—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000197	CcSEcCtD
Ropinirole—Arrhythmia—Prednisone—systemic scleroderma	0.000142	0.000196	CcSEcCtD
Ropinirole—Haematuria—Methotrexate—systemic scleroderma	0.000141	0.000195	CcSEcCtD
Ropinirole—Vomiting—Leflunomide—systemic scleroderma	0.000141	0.000194	CcSEcCtD
Ropinirole—Alopecia—Prednisone—systemic scleroderma	0.000141	0.000194	CcSEcCtD
Ropinirole—Hypersensitivity—Lisinopril—systemic scleroderma	0.00014	0.000193	CcSEcCtD
Ropinirole—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00014	0.000193	CcSEcCtD
Ropinirole—Dizziness—Mycophenolic acid—systemic scleroderma	0.00014	0.000193	CcSEcCtD
Ropinirole—Epistaxis—Methotrexate—systemic scleroderma	0.00014	0.000193	CcSEcCtD
Ropinirole—Rash—Leflunomide—systemic scleroderma	0.00014	0.000193	CcSEcCtD
Ropinirole—Dermatitis—Leflunomide—systemic scleroderma	0.000139	0.000192	CcSEcCtD
Ropinirole—Mental disorder—Prednisone—systemic scleroderma	0.000139	0.000192	CcSEcCtD
Ropinirole—Nausea—Azathioprine—systemic scleroderma	0.000139	0.000192	CcSEcCtD
Ropinirole—Headache—Leflunomide—systemic scleroderma	0.000139	0.000191	CcSEcCtD
Ropinirole—Malnutrition—Prednisone—systemic scleroderma	0.000138	0.000191	CcSEcCtD
Ropinirole—Agranulocytosis—Methotrexate—systemic scleroderma	0.000138	0.000191	CcSEcCtD
Ropinirole—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000137	0.00019	CcSEcCtD
Ropinirole—Asthenia—Lisinopril—systemic scleroderma	0.000136	0.000188	CcSEcCtD
Ropinirole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000188	CcSEcCtD
Ropinirole—Pruritus—Lisinopril—systemic scleroderma	0.000135	0.000186	CcSEcCtD
Ropinirole—Vomiting—Mycophenolic acid—systemic scleroderma	0.000134	0.000185	CcSEcCtD
Ropinirole—Haemoglobin—Methotrexate—systemic scleroderma	0.000134	0.000184	CcSEcCtD
Ropinirole—Rash—Mycophenolic acid—systemic scleroderma	0.000133	0.000184	CcSEcCtD
Ropinirole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000133	0.000184	CcSEcCtD
Ropinirole—Haemorrhage—Methotrexate—systemic scleroderma	0.000133	0.000183	CcSEcCtD
Ropinirole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000183	CcSEcCtD
Ropinirole—Headache—Mycophenolic acid—systemic scleroderma	0.000132	0.000183	CcSEcCtD
Ropinirole—Pharyngitis—Methotrexate—systemic scleroderma	0.000132	0.000182	CcSEcCtD
Ropinirole—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000182	CcSEcCtD
Ropinirole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000182	CcSEcCtD
Ropinirole—Nausea—Leflunomide—systemic scleroderma	0.000131	0.000182	CcSEcCtD
Ropinirole—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000131	0.000181	CcSEcCtD
Ropinirole—Vision blurred—Prednisone—systemic scleroderma	0.00013	0.00018	CcSEcCtD
Ropinirole—Urethral disorder—Methotrexate—systemic scleroderma	0.00013	0.00018	CcSEcCtD
Ropinirole—Diarrhoea—Lisinopril—systemic scleroderma	0.00013	0.00018	CcSEcCtD
Ropinirole—Ill-defined disorder—Prednisone—systemic scleroderma	0.000128	0.000177	CcSEcCtD
Ropinirole—Visual impairment—Methotrexate—systemic scleroderma	0.000128	0.000177	CcSEcCtD
Ropinirole—Anaemia—Prednisone—systemic scleroderma	0.000128	0.000177	CcSEcCtD
Ropinirole—Agitation—Prednisone—systemic scleroderma	0.000127	0.000176	CcSEcCtD
Ropinirole—Angioedema—Prednisone—systemic scleroderma	0.000126	0.000175	CcSEcCtD
Ropinirole—Dizziness—Lisinopril—systemic scleroderma	0.000126	0.000174	CcSEcCtD
Ropinirole—Nausea—Mycophenolic acid—systemic scleroderma	0.000125	0.000173	CcSEcCtD
Ropinirole—Malaise—Prednisone—systemic scleroderma	0.000125	0.000172	CcSEcCtD
Ropinirole—Vertigo—Prednisone—systemic scleroderma	0.000124	0.000172	CcSEcCtD
Ropinirole—Eye disorder—Methotrexate—systemic scleroderma	0.000124	0.000171	CcSEcCtD
Ropinirole—Syncope—Prednisone—systemic scleroderma	0.000124	0.000171	CcSEcCtD
Ropinirole—Tinnitus—Methotrexate—systemic scleroderma	0.000124	0.000171	CcSEcCtD
Ropinirole—Cardiac disorder—Methotrexate—systemic scleroderma	0.000123	0.00017	CcSEcCtD
Ropinirole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000169	CcSEcCtD
Ropinirole—Loss of consciousness—Prednisone—systemic scleroderma	0.000122	0.000168	CcSEcCtD
Ropinirole—Vomiting—Lisinopril—systemic scleroderma	0.000121	0.000167	CcSEcCtD
Ropinirole—Angiopathy—Methotrexate—systemic scleroderma	0.000121	0.000166	CcSEcCtD
Ropinirole—Immune system disorder—Methotrexate—systemic scleroderma	0.00012	0.000166	CcSEcCtD
Ropinirole—Rash—Lisinopril—systemic scleroderma	0.00012	0.000166	CcSEcCtD
Ropinirole—Convulsion—Prednisone—systemic scleroderma	0.00012	0.000166	CcSEcCtD
Ropinirole—Dermatitis—Lisinopril—systemic scleroderma	0.00012	0.000165	CcSEcCtD
Ropinirole—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00012	0.000165	CcSEcCtD
Ropinirole—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00012	0.000165	CcSEcCtD
Ropinirole—Hypertension—Prednisone—systemic scleroderma	0.00012	0.000165	CcSEcCtD
Ropinirole—Chills—Methotrexate—systemic scleroderma	0.000119	0.000165	CcSEcCtD
Ropinirole—Headache—Lisinopril—systemic scleroderma	0.000119	0.000164	CcSEcCtD
Ropinirole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000163	CcSEcCtD
Ropinirole—Arthralgia—Prednisone—systemic scleroderma	0.000118	0.000163	CcSEcCtD
Ropinirole—Myalgia—Prednisone—systemic scleroderma	0.000118	0.000163	CcSEcCtD
Ropinirole—Anxiety—Prednisone—systemic scleroderma	0.000117	0.000162	CcSEcCtD
Ropinirole—Alopecia—Methotrexate—systemic scleroderma	0.000117	0.000162	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000117	0.000162	CcSEcCtD
Ropinirole—Discomfort—Prednisone—systemic scleroderma	0.000116	0.000161	CcSEcCtD
Ropinirole—Mental disorder—Methotrexate—systemic scleroderma	0.000116	0.000161	CcSEcCtD
Ropinirole—Malnutrition—Methotrexate—systemic scleroderma	0.000116	0.00016	CcSEcCtD
Ropinirole—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000157	CcSEcCtD
Ropinirole—Dysgeusia—Methotrexate—systemic scleroderma	0.000113	0.000156	CcSEcCtD
Ropinirole—Nausea—Lisinopril—systemic scleroderma	0.000113	0.000156	CcSEcCtD
Ropinirole—Oedema—Prednisone—systemic scleroderma	0.000113	0.000156	CcSEcCtD
Ropinirole—Infection—Prednisone—systemic scleroderma	0.000112	0.000155	CcSEcCtD
Ropinirole—Back pain—Methotrexate—systemic scleroderma	0.000112	0.000154	CcSEcCtD
Ropinirole—Shock—Prednisone—systemic scleroderma	0.000111	0.000153	CcSEcCtD
Ropinirole—Nervous system disorder—Prednisone—systemic scleroderma	0.000111	0.000153	CcSEcCtD
Ropinirole—Tachycardia—Prednisone—systemic scleroderma	0.00011	0.000152	CcSEcCtD
Ropinirole—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000152	CcSEcCtD
Ropinirole—Skin disorder—Prednisone—systemic scleroderma	0.00011	0.000151	CcSEcCtD
Ropinirole—Hyperhidrosis—Prednisone—systemic scleroderma	0.000109	0.000151	CcSEcCtD
Ropinirole—Vision blurred—Methotrexate—systemic scleroderma	0.000109	0.00015	CcSEcCtD
Ropinirole—Anorexia—Prednisone—systemic scleroderma	0.000108	0.000149	CcSEcCtD
Ropinirole—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000107	0.000148	CcSEcCtD
Ropinirole—Anaemia—Methotrexate—systemic scleroderma	0.000107	0.000148	CcSEcCtD
Ropinirole—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000146	CcSEcCtD
Ropinirole—Rash—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000145	CcSEcCtD
Ropinirole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000145	CcSEcCtD
Ropinirole—Headache—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000144	CcSEcCtD
Ropinirole—Malaise—Methotrexate—systemic scleroderma	0.000104	0.000144	CcSEcCtD
Ropinirole—Vertigo—Methotrexate—systemic scleroderma	0.000104	0.000143	CcSEcCtD
Ropinirole—Leukopenia—Methotrexate—systemic scleroderma	0.000104	0.000143	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000103	0.000142	CcSEcCtD
Ropinirole—Insomnia—Prednisone—systemic scleroderma	0.000102	0.000141	CcSEcCtD
Ropinirole—Paraesthesia—Prednisone—systemic scleroderma	0.000101	0.00014	CcSEcCtD
Ropinirole—Cough—Methotrexate—systemic scleroderma	0.000101	0.000139	CcSEcCtD
Ropinirole—Convulsion—Methotrexate—systemic scleroderma	0.0001	0.000138	CcSEcCtD
Ropinirole—Dyspepsia—Prednisone—systemic scleroderma	9.94e-05	0.000137	CcSEcCtD
Ropinirole—Nausea—Mycophenolate mofetil—systemic scleroderma	9.9e-05	0.000137	CcSEcCtD
Ropinirole—Chest pain—Methotrexate—systemic scleroderma	9.85e-05	0.000136	CcSEcCtD
Ropinirole—Arthralgia—Methotrexate—systemic scleroderma	9.85e-05	0.000136	CcSEcCtD
Ropinirole—Myalgia—Methotrexate—systemic scleroderma	9.85e-05	0.000136	CcSEcCtD
Ropinirole—Decreased appetite—Prednisone—systemic scleroderma	9.82e-05	0.000136	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	9.78e-05	0.000135	CcSEcCtD
Ropinirole—Fatigue—Prednisone—systemic scleroderma	9.74e-05	0.000134	CcSEcCtD
Ropinirole—Discomfort—Methotrexate—systemic scleroderma	9.73e-05	0.000134	CcSEcCtD
Ropinirole—Constipation—Prednisone—systemic scleroderma	9.66e-05	0.000133	CcSEcCtD
Ropinirole—Confusional state—Methotrexate—systemic scleroderma	9.52e-05	0.000131	CcSEcCtD
Ropinirole—Infection—Methotrexate—systemic scleroderma	9.38e-05	0.000129	CcSEcCtD
Ropinirole—Feeling abnormal—Prednisone—systemic scleroderma	9.31e-05	0.000129	CcSEcCtD
Ropinirole—Nervous system disorder—Methotrexate—systemic scleroderma	9.26e-05	0.000128	CcSEcCtD
Ropinirole—Thrombocytopenia—Methotrexate—systemic scleroderma	9.24e-05	0.000128	CcSEcCtD
Ropinirole—Gastrointestinal pain—Prednisone—systemic scleroderma	9.24e-05	0.000128	CcSEcCtD
Ropinirole—Skin disorder—Methotrexate—systemic scleroderma	9.17e-05	0.000127	CcSEcCtD
Ropinirole—Hyperhidrosis—Methotrexate—systemic scleroderma	9.13e-05	0.000126	CcSEcCtD
Ropinirole—Anorexia—Methotrexate—systemic scleroderma	9e-05	0.000124	CcSEcCtD
Ropinirole—Urticaria—Prednisone—systemic scleroderma	8.97e-05	0.000124	CcSEcCtD
Ropinirole—Body temperature increased—Prednisone—systemic scleroderma	8.93e-05	0.000123	CcSEcCtD
Ropinirole—Abdominal pain—Prednisone—systemic scleroderma	8.93e-05	0.000123	CcSEcCtD
Ropinirole—Hypotension—Methotrexate—systemic scleroderma	8.82e-05	0.000122	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	8.6e-05	0.000119	CcSEcCtD
Ropinirole—Insomnia—Methotrexate—systemic scleroderma	8.54e-05	0.000118	CcSEcCtD
Ropinirole—Paraesthesia—Methotrexate—systemic scleroderma	8.48e-05	0.000117	CcSEcCtD
Ropinirole—Dyspnoea—Methotrexate—systemic scleroderma	8.42e-05	0.000116	CcSEcCtD
Ropinirole—Somnolence—Methotrexate—systemic scleroderma	8.39e-05	0.000116	CcSEcCtD
Ropinirole—Hypersensitivity—Prednisone—systemic scleroderma	8.32e-05	0.000115	CcSEcCtD
Ropinirole—Dyspepsia—Methotrexate—systemic scleroderma	8.31e-05	0.000115	CcSEcCtD
Ropinirole—Decreased appetite—Methotrexate—systemic scleroderma	8.21e-05	0.000113	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Methotrexate—systemic scleroderma	8.15e-05	0.000113	CcSEcCtD
Ropinirole—Fatigue—Methotrexate—systemic scleroderma	8.14e-05	0.000112	CcSEcCtD
Ropinirole—Asthenia—Prednisone—systemic scleroderma	8.11e-05	0.000112	CcSEcCtD
Ropinirole—Pain—Methotrexate—systemic scleroderma	8.07e-05	0.000111	CcSEcCtD
Ropinirole—Pruritus—Prednisone—systemic scleroderma	7.99e-05	0.00011	CcSEcCtD
Ropinirole—Feeling abnormal—Methotrexate—systemic scleroderma	7.78e-05	0.000107	CcSEcCtD
Ropinirole—Diarrhoea—Prednisone—systemic scleroderma	7.73e-05	0.000107	CcSEcCtD
Ropinirole—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.72e-05	0.000107	CcSEcCtD
Ropinirole—Urticaria—Methotrexate—systemic scleroderma	7.5e-05	0.000104	CcSEcCtD
Ropinirole—Dizziness—Prednisone—systemic scleroderma	7.47e-05	0.000103	CcSEcCtD
Ropinirole—Body temperature increased—Methotrexate—systemic scleroderma	7.46e-05	0.000103	CcSEcCtD
Ropinirole—Abdominal pain—Methotrexate—systemic scleroderma	7.46e-05	0.000103	CcSEcCtD
Ropinirole—Vomiting—Prednisone—systemic scleroderma	7.18e-05	9.91e-05	CcSEcCtD
Ropinirole—Rash—Prednisone—systemic scleroderma	7.12e-05	9.83e-05	CcSEcCtD
Ropinirole—Dermatitis—Prednisone—systemic scleroderma	7.12e-05	9.82e-05	CcSEcCtD
Ropinirole—Headache—Prednisone—systemic scleroderma	7.08e-05	9.77e-05	CcSEcCtD
Ropinirole—Hypersensitivity—Methotrexate—systemic scleroderma	6.96e-05	9.6e-05	CcSEcCtD
Ropinirole—Asthenia—Methotrexate—systemic scleroderma	6.77e-05	9.35e-05	CcSEcCtD
Ropinirole—Nausea—Prednisone—systemic scleroderma	6.71e-05	9.26e-05	CcSEcCtD
Ropinirole—Pruritus—Methotrexate—systemic scleroderma	6.68e-05	9.22e-05	CcSEcCtD
Ropinirole—Diarrhoea—Methotrexate—systemic scleroderma	6.46e-05	8.92e-05	CcSEcCtD
Ropinirole—Dizziness—Methotrexate—systemic scleroderma	6.24e-05	8.62e-05	CcSEcCtD
Ropinirole—Vomiting—Methotrexate—systemic scleroderma	6e-05	8.29e-05	CcSEcCtD
Ropinirole—Rash—Methotrexate—systemic scleroderma	5.95e-05	8.22e-05	CcSEcCtD
Ropinirole—Dermatitis—Methotrexate—systemic scleroderma	5.95e-05	8.21e-05	CcSEcCtD
Ropinirole—Headache—Methotrexate—systemic scleroderma	5.91e-05	8.16e-05	CcSEcCtD
Ropinirole—Nausea—Methotrexate—systemic scleroderma	5.61e-05	7.74e-05	CcSEcCtD
